Glp3-Rt Side Effects: A Review of Adverse Events Reported in Published Research
Quick answer: In the published Phase 2 trial of Glp3-Rt, the most common adverse events were gastrointestinal; they were dose-related, they were mostly mild to moderate in severity, and they were partly reduced by starting at a lower dose. The trial also reported dose-dependent increases in heart rate that peaked around 24 weeks and declined […]